Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Seer Inc Cl A
(NQ:
SEER
)
1.860
-0.070 (-3.63%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
502,769
Open
1.900
Bid (Size)
1.800 (2)
Ask (Size)
1.970 (1)
Prev. Close
1.930
Today's Range
1.825 - 1.965
52wk Range
1.455 - 5.650
Shares Outstanding
65,088,575
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Seer Proteograph™ Provides Differentiated Insights into Spaceflight Proteomic Alterations for Precision Medicine and Biomarker Discovery
June 11, 2024
From
Seer, Inc.
Via
GlobeNewswire
Seer Technology Access Center Provides Unprecedented Scale and Depth of Coverage for PrognomiQ’s Early Cancer Detection Study
June 02, 2024
Combined Workflow of Proteograph™ XT Assay and Thermo Scientific™ Orbitrap™ Astral™ Mass Spectrometer Robustly Identifies over 13,000 Protein Groups Across a Study of 2,840 Subjects
From
Seer, Inc.
Via
GlobeNewswire
Performance
YTD
-4.12%
-4.12%
1 Month
+8.14%
+8.14%
3 Month
+10.06%
+10.06%
6 Month
+10.06%
+10.06%
1 Year
-63.02%
-63.02%
More News
Read More
SEER Stock Earnings: Seer Meets EPS, Misses Revenue for Q1 2024
May 08, 2024
Via
InvestorPlace
Seer Reports First Quarter 2024 Financial Results
May 08, 2024
From
Seer, Inc.
Via
GlobeNewswire
Recap: Seer Q4 Earnings
February 29, 2024
Via
Benzinga
Earnings Scheduled For February 29, 2024
February 29, 2024
Via
Benzinga
Seer Launches New Technology Access Center in Europe to Expand Accessibility to Unbiased Proteomic Solutions
May 08, 2024
From
Seer, Inc.
Via
GlobeNewswire
Seer to Report First Quarter 2024 Financial Results on May 8, 2024
April 23, 2024
From
Seer, Inc.
Via
GlobeNewswire
Seer Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Outlook
February 29, 2024
From
Seer, Inc.
Via
GlobeNewswire
Seer to Participate in the TD Cowen 44th Annual Health Care Conference
February 21, 2024
From
Seer, Inc.
Via
GlobeNewswire
Zoom Video And 2 Other Stocks Insiders Are Selling
February 08, 2024
Via
Benzinga
Seer Proteograph™ Enables Unprecedented Genetic Marker Mapping for Proteogenomics Studies to Advance Drug and Biomarker Discovery
February 06, 2024
From
Seer, Inc.
Via
GlobeNewswire
Seer to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024
February 01, 2024
From
Seer, Inc.
Via
GlobeNewswire
Seer to Present at the J.P. Morgan 42nd Annual Health Care Conference
December 21, 2023
From
Seer, Inc.
Via
GlobeNewswire
Seer to Present at the Canaccord MedTech, Diagnostics and Digital Health & Services Forum
November 10, 2023
From
Seer, Inc.
Via
GlobeNewswire
Seer Wins Proteomics Solution of the Year by BioTech Breakthrough and Named #5 on Deloitte Technology Fast 500
November 08, 2023
From
Seer, Inc.
Via
GlobeNewswire
Seer Reports Third Quarter 2023 Financial Results
November 07, 2023
From
Seer, Inc.
Via
GlobeNewswire
Earnings Scheduled For November 7, 2023
November 07, 2023
Via
Benzinga
Seer Announces Addition of Panome Bio to Centers of Excellence (COE) Program
November 01, 2023
From
Seer, Inc.
Via
GlobeNewswire
Seer to Report Third Quarter 2023 Financial Results on November 7, 2023
October 19, 2023
From
Seer, Inc.
Via
GlobeNewswire
7 Contrarian Stocks to Buy for the High-Stakes Gambler
September 28, 2023
Via
InvestorPlace
Stocks That Hit 52-Week Lows On Thursday
September 21, 2023
Via
Benzinga
Seer to Participate in Upcoming September Investor Conferences
September 08, 2023
From
Seer, Inc.
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Wednesday
August 23, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
August 10, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.